HK-listed Jinxin Fertility Group jumps on expansion deals

Jinxin Fertility

21/06/2021 04:37

** Shares of China's assisted reproductive services provider
Jinxin Fertility Group Ltd  1951.HK  rise as much as 13.6% to
HK$20.90, their biggest intraday percentage gain since May 31
    ** Stock, the eighth biggest percentage gainer on the Hong
Kong bourse, hits its highest since June 4
    ** The Sichuan-based company says its unit has agreed to buy
a 10% stake in Guangdong Kangzhi Hospital Management Co Ltd from
Honz Pharmaceutical Co Ltd  300086.SZ  for 37.7 mln yuan ($5.8
mln)  urn:newsml:reuters.com:*:nFWN2O00KJ
    ** Says its 15%-owned Tianjin Binhai Yuanxian Management
Consulting Center will buy from Honz and certain independent
third parties 90% of Guangdong Kangzhi Hospital, and stakes in
Yunnan Jiuzhou Hospital and Kunming Hewanjia Obstetrics and
Gynecology Hospital 
    ** Says the acquisitions will expand productivity and
capacity of its network in mainland China 
    ** Shenzhen shares of Honz  300086.SZ  rise 1.4%
    ** The Hong Kong Hang Seng Commerce & Industry Index  .HSNC 
slips 0.4%, while the healthcare index  .HSCIH  rises 1.7%
    ** The Hang Seng China enterprises index  .HSCE  slides 0.8%
and the benchmark index  .HSI  drops 1.1%
    ** As of last close, the stock had surged 16.5% this year


($1 = 6.4536 Chinese yuan renminbi)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))